Bio-Rad Laboratories Price to Sales Ratio 2012-2025 | BIO
Historical PS ratio values for Bio-Rad Laboratories (BIO) over the last 10 years. The current P/S ratio for Bio-Rad Laboratories as of March 10, 2026 is .
| Bio-Rad Laboratories P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2026-03-11 | 269.89 | 2.85 | |
| 2025-12-31 | 302.99 | $94.79 | 3.20 |
| 2025-09-30 | 280.39 | $92.78 | 3.02 |
| 2025-06-30 | 241.32 | $91.75 | 2.63 |
| 2025-03-31 | 243.56 | $90.30 | 2.70 |
| 2024-12-31 | 328.51 | $90.76 | 3.62 |
| 2024-09-30 | 334.58 | $90.43 | 3.70 |
| 2024-06-30 | 273.11 | $88.84 | 3.07 |
| 2024-03-31 | 345.87 | $89.56 | 3.86 |
| 2023-12-31 | 322.89 | $90.91 | 3.55 |
| 2023-09-30 | 358.45 | $92.10 | 3.89 |
| 2023-06-30 | 379.12 | $93.37 | 4.06 |
| 2023-03-31 | 479.02 | $93.36 | 5.13 |
| 2022-12-31 | 420.49 | $94.00 | 4.47 |
| 2022-09-30 | 417.14 | $93.74 | 4.45 |
| 2022-06-30 | 495.00 | $95.56 | 5.18 |
| 2022-03-31 | 563.23 | $96.11 | 5.86 |
| 2021-12-31 | 755.57 | $96.80 | 7.81 |
| 2021-09-30 | 745.95 | $98.73 | 7.56 |
| 2021-06-30 | 644.29 | $95.50 | 6.75 |
| 2021-03-31 | 571.17 | $89.61 | 6.37 |
| 2020-12-31 | 582.94 | $84.46 | 6.90 |
| 2020-09-30 | 515.46 | $78.96 | 6.53 |
| 2020-06-30 | 451.49 | $76.27 | 5.92 |
| 2020-03-31 | 350.56 | $77.40 | 4.53 |
| 2019-12-31 | 370.03 | $76.87 | 4.81 |
| 2019-09-30 | 332.74 | $76.59 | 4.34 |
| 2019-06-30 | 312.59 | $75.79 | 4.12 |
| 2019-03-31 | 305.68 | $75.86 | 4.03 |
| 2018-12-31 | 232.22 | $75.74 | 3.07 |
| 2018-09-30 | 312.99 | $76.02 | 4.12 |
| 2018-06-30 | 288.54 | $75.80 | 3.81 |
| 2018-03-31 | 250.08 | $73.56 | 3.40 |
| 2017-12-31 | 238.67 | $72.00 | 3.31 |
| 2017-09-30 | 222.22 | $70.59 | 3.15 |
| 2017-06-30 | 226.31 | $69.96 | 3.23 |
| 2017-03-31 | 199.34 | $70.61 | 2.82 |
| 2016-12-31 | 182.28 | $69.86 | 2.61 |
| 2016-09-30 | 163.81 | $69.98 | 2.34 |
| 2016-06-30 | 143.02 | $68.80 | 2.08 |
| 2016-03-31 | 136.72 | $68.56 | 1.99 |
| 2015-12-31 | 138.66 | $68.73 | 2.02 |
| 2015-09-30 | 134.31 | $69.87 | 1.92 |
| 2015-06-30 | 150.61 | $72.11 | 2.09 |
| 2015-03-31 | 135.18 | $73.34 | 1.84 |
| 2014-12-31 | 120.56 | $74.72 | 1.61 |
| 2014-09-30 | 113.40 | $75.04 | 1.51 |
| 2014-06-30 | 119.71 | $74.49 | 1.61 |
| 2014-03-31 | 128.12 | $74.23 | 1.73 |
| 2013-12-31 | 123.61 | $74.04 | 1.67 |
| 2013-09-30 | 117.56 | $73.23 | 1.61 |
| 2013-06-30 | 112.20 | $72.98 | 1.54 |
| 2013-03-31 | 126.00 | $72.62 | 1.73 |
| 2012-12-31 | 105.05 | $72.32 | 1.45 |
| 2012-09-30 | 106.72 | $71.61 | 1.49 |
| 2012-06-30 | 100.01 | $72.35 | 1.38 |
| 2012-03-31 | 103.69 | $72.82 | 1.42 |
| 2011-12-31 | 96.04 | $72.87 | 1.32 |
| 2011-09-30 | 90.77 | $72.51 | 1.25 |
| 2011-06-30 | 119.36 | $71.13 | 1.68 |
| 2011-03-31 | 120.14 | $69.45 | 1.73 |
| 2010-12-31 | 103.85 | $68.55 | 1.52 |
| 2010-09-30 | 90.51 | $67.38 | 1.34 |
| 2010-06-30 | 86.49 | $67.14 | 1.29 |
| 2010-03-31 | 103.52 | $65.91 | 1.57 |
| 2009-12-31 | 96.46 | $64.25 | 1.50 |
| 2009-09-30 | 91.88 | $62.66 | 1.47 |
| 2009-06-30 | 75.48 | $62.05 | 1.22 |
| 2009-03-31 | 65.90 | $63.06 | 1.05 |
| 2008-12-31 | 75.31 | $63.87 | 1.18 |
| 2008-09-30 | 99.12 | $64.51 | 1.54 |
| 2008-06-30 | 80.89 | $61.04 | 1.33 |
| 2008-03-31 | 88.95 | $57.12 | 1.56 |
| 2007-12-31 | 103.62 | $53.66 | 1.93 |
| 2007-09-30 | 90.50 | $49.55 | 1.83 |
| 2007-06-30 | 75.57 | $48.39 | 1.56 |
| 2007-03-31 | 69.84 | $47.72 | 1.46 |
| 2006-12-31 | 82.52 | $47.34 | 1.74 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $6.921B | $2.583B |
| Bio-Rad Laboratories is a manufacturer and global supplier of clinical diagnostics and life science research products in the healthcare, analytical chemistry life science research and other markets. It offers a wide portfolio of products and systems which allow the separation of complex chemical and biological materials and discovery, analysis and purification of their components. Bio-Rad has extensive and direct distribution channels outside the United States through subsidiaries which focus on sales, customer service and product distribution. The company operates through two reportable segments - Life Science segment which designs, manufactures, markets and services reagents, apparatus and instruments utilized for biological research. Clinical Diagnostics - This business markets and distributes products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians office laboratories, transfusion laboratories as well as insurance and forensic testing laboratories. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $195.936B | 21.88 |
| EssilorLuxottica (ESLOY) | France | $142.091B | 0.00 |
| Stryker (SYK) | United States | $140.083B | 26.86 |
| Medtronic (MDT) | Ireland | $127.548B | 17.67 |
| Boston Scientific (BSX) | United States | $110.783B | 24.50 |
| Medline (MDLN) | United States | $58.526B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.093B | 0.00 |
| ResMed (RMD) | United States | $36.791B | 24.57 |
| GE HealthCare Technologies (GEHC) | United States | $36.615B | 17.54 |
| Agilent Technologies (A) | United States | $35.584B | 22.55 |
| Koninklijke Philips (PHG) | Netherlands | $30.091B | 17.86 |
| Terumo (TRUMY) | Japan | $21.610B | 25.26 |
| Zimmer Biomet Holdings (ZBH) | United States | $19.115B | 11.76 |
| Insulet (PODD) | United States | $17.076B | 53.00 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $15.372B | 0.00 |
| Baxter (BAX) | United States | $10.182B | 8.72 |
| Sunny Optical Technology (SNPTF) | China | $8.485B | 0.00 |
| Demant (WILYY) | Denmark | $6.042B | 0.00 |
| Envista Holdings (NVST) | United States | $4.747B | 24.14 |
| Lantheus Holdings (LNTH) | United States | $4.601B | 14.02 |
| BillionToOne (BLLN) | United States | $4.056B | 0.00 |
| ICU Medical (ICUI) | United States | $3.577B | 22.71 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.263B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.160B | 14.91 |
| Haemonetics (HAE) | United States | $2.684B | 11.74 |
| Neogen (NEOG) | United States | $2.380B | 52.10 |
| Phibro Animal Health (PAHC) | United States | $2.118B | 18.66 |
| Perrigo (PRGO) | Ireland | $2.001B | 5.01 |
| LeMaitre Vascular (LMAT) | United States | $1.989B | 40.03 |
| Curaleaf Holdings (CURLF) | Canada | $1.642B | 0.00 |
| AtriCure (ATRC) | United States | $1.623B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.602B | 11.12 |
| Kestra Medical Technologies (KMTS) | United States | $1.571B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.446B | 63.36 |
| AdaptHealth (AHCO) | United States | $1.381B | 20.00 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.358B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.070B | 317.57 |
| Capricor Therapeutics (CAPR) | United States | $1.026B | 0.00 |
| InMode (INMD) | Israel | $0.906B | 9.93 |
| Tilray Brands (TLRY) | Canada | $0.875B | 0.00 |
| Valneva SE (VALN) | France | $0.868B | 0.00 |
| Omeros (OMER) | United States | $0.829B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.757B | 0.00 |
| CeriBell (CBLL) | United States | $0.733B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.566B | 13.52 |
| Brainsway (BWAY) | Israel | $0.451B | 76.63 |
| Canopy Growth (CGC) | Canada | $0.436B | 0.00 |
| Cerus (CERS) | United States | $0.430B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.396B | 0.00 |
| SNDL (SNDL) | Canada | $0.386B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.361B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.328B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.315B | 25.09 |
| Evolus (EOLS) | United States | $0.279B | 0.00 |
| Quanterix (QTRX) | United States | $0.268B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.243B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Sanuwave Health (SNWV) | United States | $0.213B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.205B | 18.42 |
| High Tide (HITI) | Canada | $0.203B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.201B | 59.17 |
| OraSure Technologies (OSUR) | United States | $0.197B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.182B | 0.00 |
| Organigram Global (OGI) | Canada | $0.174B | 0.00 |
| Accendra Health (ACH) | United States | $0.173B | 1.74 |
| Vireo Growth (VREOF) | United States | $0.170B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.168B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Apyx Medical (APYX) | United States | $0.142B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.134B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.129B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.42 |
| MacroGenics (MGNX) | United States | $0.108B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.100B | 0.00 |
| Biote (BTMD) | United States | $0.097B | 4.26 |
| Exagen (XGN) | United States | $0.074B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 25.39 |
| Sharps Technology (STSS) | United States | $0.051B | 0.00 |
| Nephros (NEPH) | United States | $0.044B | 31.54 |
| Cytosorbents (CTSO) | United States | $0.040B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.040B | 0.00 |
| Veru (VERU) | United States | $0.037B | 0.00 |
| Modular Medical (MODD) | United States | $0.035B | 0.00 |
| United-Guardian (UG) | United States | $0.030B | 15.35 |
| Jin Medical (ZJYL) | China | $0.022B | 0.00 |
| Bonk (BNKK) | United States | $0.021B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.014B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| INLIF (INLF) | China | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Agape ATP (ATPC) | $0.002B | 0.00 | |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |